Incidence rates (A) (events per 100 patient years), treatment effect of empagliflozin compared with placebo (B), and estimated cumulative incidence function (C) for hypertensive urgencies according to different criteria. Treatment effect based on Cox regression model adjusted for age, baseline estimated glomerular filtration rate (Chronic Kidney Disease Epidemiology Collaboration formula), baseline left ventricular ejection fraction as linear covariates and region, baseline diabetes status, and sex. Patients with increased blood pressure values at baseline were not at risk for occurrence of the respective endpoint. AE, adverse event; CI, confidence interval; DBP; diastolic blood pressure; HR, hazard ratio; SBP, systolic blood pressure